JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
ETNB
2351
DELISTED
89bio
ETNB
| $8.13M | ﹤0.01% |
534,105
+390,176
| +271% | +$5.09M |
2019 Q4
13 quarters
|
|
|
RDUS
2352
DELISTED
Radius Recycling
RDUS
| $8.13M | ﹤0.01% |
261,462
-25,899
| -9% | -$840K |
2013 Q2
39 quarters
|
|
2353
AeroVironment
AVAV
$7.21B
| $8.12M | ﹤0.01% |
88,608
+50,419
| +132% | +$4.46M |
2016 Q3
26 quarters
|
|
2354
Kforce
KFRC
$921M
| $8.11M | ﹤0.01% |
128,269
-25,336
| -16% | -$1.51M |
2015 Q4
29 quarters
|
|
2355
Compañía de Minas Buenaventura
BVN
$7.91B
| $8.11M | ﹤0.01% |
991,322
+924,791
| +1,390% | +$7.37M |
2013 Q2
39 quarters
|
|
2356
PUT
Coinbase
COIN
$50.3B
| $8.11M | ﹤0.01% |
120,000
| – | – |
2021 Q2
7 quarters
|
|
2357
Impinj
PI
$5.76B
| $8.11M | ﹤0.01% |
59,803
-5,823
| -9% | -$742K |
2016 Q3
26 quarters
|
|
2358
Utah Medical Products
UTMD
$235M
| $8.1M | ﹤0.01% |
85,468
+2,255
| +3% | +$207K |
2015 Q3
30 quarters
|
|
|
AKRO
2359
DELISTED
Akero Therapeutics
AKRO
| $8.09M | ﹤0.01% |
211,468
+28,153
| +15% | +$1.26M |
2019 Q3
14 quarters
|
|
2360
Four Corners Property Trust
FCPT
$2.34B
| $8.09M | ﹤0.01% |
300,998
-7,089
| -2% | -$195K |
2015 Q4
29 quarters
|
|
2361
Rentokil
RTO
$10B
| $8.08M | ﹤0.01% |
221,181
-1,247,278
| -85% | -$39.4M |
2022 Q4
1 quarter
|
|
2362
Woodside Energy
WDS
$41.3B
| $8.07M | ﹤0.01% |
359,896
+187,484
| +109% | +$4.5M |
2022 Q2
3 quarters
|
|
2363
1-800-Flowers.com
FLWS
$162M
| $8.07M | ﹤0.01% |
701,844
+686,436
| +4,455% | +$7.02M |
2017 Q4
21 quarters
|
|
2364
Brookfield Asset Management
BAM
$71.6B
| $8.06M | ﹤0.01% |
246,367
+78,721
| +47% | +$2.56M |
2022 Q4
1 quarter
|
|
2365
California Water Service
CWT
$2.86B
| $8.05M | ﹤0.01% |
138,231
+42,077
| +44% | +$2.5M |
2013 Q2
39 quarters
|
|
2366
PUT
Constellation Energy
CEG
$107B
| $8.05M | ﹤0.01% |
+102,500
| New | +$8.29M |
2023 Q1
0 quarters
|
|
2367
CALL
Ascendis Pharma A/S
ASND
$14.7B
| $8.04M | ﹤0.01% |
+75,000
| New | +$8.58M |
2023 Q1
0 quarters
|
|
|
SILK
2368
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $8.04M | ﹤0.01% |
205,460
+102,661
| +100% | +$5.02M |
2019 Q2
15 quarters
|
|
2369
Array Technologies
ARRY
$627M
| $8.04M | ﹤0.01% |
367,302
-61,405
| -14% | -$1.26M |
2020 Q4
9 quarters
|
|
2370
La-Z-Boy
LZB
$1.18B
| $8.04M | ﹤0.01% |
276,304
+34,978
| +14% | +$995K |
2013 Q2
39 quarters
|
|
2371
Lexicon Pharmaceuticals
LXRX
$774M
| $8.03M | ﹤0.01% |
3,305,991
+29,193
| +0.9% | +$66.9K |
2015 Q3
30 quarters
|
|
|
TBRG
2372
DELISTED
TruBridge
TBRG
| $8.02M | ﹤0.01% |
265,455
+25,510
| +11% | +$743K |
2016 Q3
26 quarters
|
|
2373
Check Point Software Technologies
CHKP
$13.5B
| $8.02M | ﹤0.01% |
61,661
-19,175
| -24% | -$2.44M |
2013 Q2
39 quarters
|
|
2374
FTAI Aviation
FTAI
$17.4B
| $7.99M | ﹤0.01% |
285,897
-378,614
| -57% | -$8.94M |
2021 Q1
8 quarters
|
|
2375
iHeartMedia
IHRT
$316M
| $7.99M | ﹤0.01% |
2,048,548
+21,540
| +1% | +$137K |
2019 Q3
14 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.